Log in

STAAR Surgical Stock Forecast, Price & News

+1.37 (+1.86 %)
(As of 12/3/2020 12:00 AM ET)
Today's Range
Now: $75.09
50-Day Range
MA: $74.25
52-Week Range
Now: $75.09
Volume333,437 shs
Average Volume557,998 shs
Market Capitalization$3.46 billion
P/E Ratio469.34
Dividend YieldN/A
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Lake Forest, California.
STAAR Surgical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.40 out of 5 stars

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:STAA



Sales & Book Value

Annual Sales$150.18 million
Cash Flow$0.63 per share
Book Value$3.59 per share


Net Income$14.05 million


Market Cap$3.46 billion
Next Earnings Date2/24/2021 (Estimated)
+1.37 (+1.86 %)
(As of 12/3/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

How has STAAR Surgical's stock price been impacted by COVID-19?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, STAA shares have increased by 168.1% and is now trading at $75.09.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of STAAR Surgical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for STAAR Surgical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than STAAR Surgical?

Wall Street analysts have given STAAR Surgical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STAAR Surgical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for STAAR Surgical

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings data on Monday, November, 9th. The medical instruments supplier reported $0.14 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.09 by $0.05. The medical instruments supplier had revenue of $47.10 million for the quarter, compared to analysts' expectations of $42.99 million. STAAR Surgical had a return on equity of 8.78% and a net margin of 5.03%. The company's revenue was up 20.5% on a year-over-year basis. During the same period last year, the business earned $0.05 EPS.
View STAAR Surgical's earnings history

What price target have analysts set for STAA?

6 brokers have issued 1-year target prices for STAAR Surgical's shares. Their forecasts range from $41.00 to $84.00. On average, they expect STAAR Surgical's stock price to reach $61.17 in the next twelve months. This suggests that the stock has a possible downside of 18.5%.
View analysts' price targets for STAAR Surgical

Who are some of STAAR Surgical's key competitors?

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), The Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), The Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:
  • Ms. Caren L. Mason, CEO, Pres & Director (Age 66, Pay $1.19M)
  • Dr. Keith Holliday, Chief Technology Officer (Age 57, Pay $597.39k)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations and Director of Markets - Europe & China (Age 55, Pay $561.19k)
  • Dr. Scott D. Barnes M.D., Chief Medical Officer (Age 58, Pay $681.32k)
  • Mr. Patrick F. Williams, Chief Financial Officer (Age 47)
  • Mr. Graydon C. Hansen, Sr. VP of Global Operations (Age 61)
  • Mr. Brian Moore, VP of Investor, Media Relations & Corp. Devel.
  • Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 58)
  • Mr. William Goodmen, VP of Global HR (Age 65)
  • Mr. James Francese, Sr. VP of Commercial Operations - North America & APAC (Age 56)

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Broadwood Capital Inc. (23.41%), BlackRock Inc. (7.30%), State Street Corp (2.22%), Elephas Investment Management Ltd (2.18%), Defender Capital LLC. (1.29%) and Morgan Stanley (1.02%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, Jon K Hayashida, Keith Holliday, Samuel J Gesten and Scott D Barnes.
View institutional ownership trends for STAAR Surgical

Which major investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., KAMES CAPITAL plc, Ziegler Capital Management LLC, Grandeur Peak Global Advisors LLC, Sei Investments Co., State Street Corp, TCW Group Inc., and Wells Fargo & Company MN. Company insiders that have sold STAAR Surgical company stock in the last year include Deborah J Andrews, Hans-Martin Blickensdoerfer, Jon K Hayashida, Keith Holliday, and Samuel J Gesten.
View insider buying and selling activity for STAAR Surgical

Which major investors are buying STAAR Surgical stock?

STAA stock was bought by a variety of institutional investors in the last quarter, including Elephas Investment Management Ltd, BlackRock Inc., Morgan Stanley, Assenagon Asset Management S.A., Charles Schwab Investment Management Inc., Defender Capital LLC., Skandinaviska Enskilda Banken AB publ, and Royce & Associates LP.
View insider buying and selling activity for STAAR Surgical

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $75.09.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $3.46 billion and generates $150.18 million in revenue each year. The medical instruments supplier earns $14.05 million in net income (profit) each year or $0.46 on an earnings per share basis. STAAR Surgical employs 550 workers across the globe.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.